A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts

Donna P. Ankerst, Johanna Straubinger, Katharina Selig, Lourdes Guerrios, Amanda De Hoedt, Javier Hernandez, Michael A. Liss, Robin J. Leach, Stephen J. Freedland, Michael W. Kattan, Robert Nam, Alexander Haese, Francesco Montorsi, Stephen A. Boorjian, Matthew R. Cooperberg, Cedric Poyet, Emily Vertosick, Andrew J. Vickers

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

A North American multicohort-based risk tool for predicting prostate cancer outcomes on biopsy has been developed and outperformed a leading North American risk tool in validation. It is now available online for patients and their providers.

Original languageEnglish (US)
Pages (from-to)197-203
Number of pages7
JournalEuropean urology
Volume74
Issue number2
DOIs
StatePublished - Aug 2018

Keywords

  • Digital rectal exam
  • Family history
  • High-grade disease
  • Prostate cancer
  • Prostate-specific antigen
  • Risk prediction

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts'. Together they form a unique fingerprint.

  • Cite this

    Ankerst, D. P., Straubinger, J., Selig, K., Guerrios, L., De Hoedt, A., Hernandez, J., Liss, M. A., Leach, R. J., Freedland, S. J., Kattan, M. W., Nam, R., Haese, A., Montorsi, F., Boorjian, S. A., Cooperberg, M. R., Poyet, C., Vertosick, E., & Vickers, A. J. (2018). A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. European urology, 74(2), 197-203. https://doi.org/10.1016/j.eururo.2018.05.003